ABSTRACT The cellular fate of insulin receptors in isolated rat adipocytes was studied by using a biologically active photosensitive insulin derivative, 'B(2-nitro4-azidophenylacetyl)-~des-Phe B insulin (NAPA-DP-insulin), to photoaffinity label the insulin receptors. Insulin receptors specifically labeled with "SI-labeled NAPA-DP-insulin were identified by NaDodSO/polyacrylamide gel electrophoresis and autoradiography. Under nonreducing conditions, specific bands ofMr 330,000, 295,000, and 260,000 were identified; under disulfide reducing conditions, these were converted into Mr 125,000 and 90,000 subunits. When cells labeled at 16°C were immediately trypsinized, all of the receptor bands were degraded into lower molecular weight fragments, indicating that the labeled receptors were all on the cell surface. However, when the labeled cells were incubated at 370C for 1 hr prior to trypsin exposure, "30% of the receptors were found to be trypsin insensitive, indicating that this fraction was translocated intracellularly. Processing of the insulin receptors appeared to occur; incubation at 37C (but not at 16'C) resulted in generation of a Mr 115,000 component from the Mr 125,000 subunit as well as in the disappearance of the Mr 330,000 and 295,000 species. Inclusion of chloroquine during photoaffinity labeling at 16°C and during the subsequent incubation at 37C showed that this agent (i) increased the trypsin-insensitive (intracellular) receptor pool, (ii) blocked conversion of the Mr 125,000 subunit into the Mr 1,15,000 component, and (iii) prevented the disappearance of the Mr 330,000 and 295,000 species. These studies show that insulinreceptor complexes are internalized and processed intracellularly at a chloroquine-sensitive site(s).
Several recent morphologic and biochemical studies have shown that, following initial cell surface binding, a portion of bound insulin is internalized by adsorptive endocytosis and subsequently degraded intracellularly (for review, see ref. 1) . Also, it is suggested that the receptor is internalized along with insulin (2, 3) and that this process participates in the insulin-induced receptor loss (down regulation) observed in various cell types (4) (5) (6) (7) . However, since almost all of the reported studies have followed the fate of radiolabeled insulin, conclusions regarding the fate of the receptor itself have been based on indirect evidence. Thus, it becomes necessary to use experimental techniques by which the receptor can be followed directly. Recently, the techniques of chemical crosslinking (8, 9) and photoaffinity labeling (10) (11) (12) (13) have been used to identify the insulin receptor and study its subunit structure in a variety of tissues. Of these techniques, receptor photoaffinity labeling is an attractive approach to studies ofthe dynamics ofinsulin-receptor interaction in living cells and of the metabolic fate of the receptor. This is because covalent attachment of insulin to its receptor occurs at the ligand binding site (without perturbation of other cellular proteins) and the timing ofcovalent bond formation can also be conveniently determined.
We have used a biologically active photosensitive insulin derivative to photoaffinity label insulin receptors in intact isolated rat adipocytes and provide direct evidence that insulin-receptor complexes are internalized and processed intracellularly.
MATERIALS AND METHODS Materials. The preparation, characterization, and biological activity ofthe photosensitive insulin derivative used in our studies, B2(2-nito-4-azidophenylacetyl)-des-Phe"-insulin (NAPA-DP-insulin), have been described (14) (15) (16) . Carrier-free Na'25I was purchased from Amersham, collagenase was from Worthington, bovine serum albumin (fraction V) was from Armour Pharmaceuticals (Chicago, IL), soybean trypsin inhibitor was from GIBCO. Phenylmethylsulfonyl fluoride (BzlSO2F), Nethylmaleimide (MalNEt), chloroquine, Triton X-100, and trypsin were purchased from Sigma. Porcine monocomponent insulin was generously supplied by Ronald E. Chance of Eli Lilly.
lodination of the Photoreactive Insulin Derivative. NAPA-DP-insulin was iodinated (in a dark room) to a specific activity of80-130 cpm/pg by using the water-insoluble oxidizing agent, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril (IODO-GEN; Pierce) coated as a film (40 ,ug in 20 ,ul of chloroform) at the bottom of 12 x 75 mm glass tubes. Ten micrograms of NAPA-DP-insulin in 0.01 M HCI was allowed to react for 1 min with 2 mCi (1 Ci = 3.7 x 1010 becquerels) of Na125I in 200 ,ul of 0.1 M phosphate buffer (pH 7.5) in the IODO-GEN tube. The reaction mixture was then transferred to a clean test tube, the volume was adjusted to 2.5 ml with 0.1 M phosphate buffer, and 50 ,ul of 10% bovine serum albumin was added. This mixture was dialyzed to remove free 125I, and the iodinated product was stored at 4°C and used within 1 to 2 wk.
Preparation of Isolated Adipocytes and Measurement of Binding to Intact Cells. Isolated adipocytes were prepared from the epididymal fat pads of male Sprague-Dawley rats by the collagenase digestion method (7, 17) . Measurement of '"I-labeled NAPA-DP-insulin (NAPA-DP-'"I-insulin) binding to intact cells was carried out as described (7) .
Binding and Photolysis of NAPA-DP-'25I-Insulin. Suspensions ofisolated adipocytes (1 x .106 cells/ml) were incubated in plastic vials in the dark at 16°C with various concentrations of NAPA-DP-l25I-insulin in the presence or absence of chloAbbreviations: NAPA-DP-insulin, B2(2-nitro4-azidophenylacetyl)-desPheBl-insulin; NAPA-DP-l25I-insulin, l25I-labeled NAPA-DP-insulin; BzlSO2F, phenylmethylsulfonyl fluoride; MalNEt, N-ethylmaleimide.
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The incubation buffer was 120 mM NaCl/5 mM KCV1.2 mM MgSO42 mM CaCl2/10 mM dextrose/24 mM NaOAc/35 mM Tris.HCV1% bovine serum albumin, pH 7.6. After incubation, the cells were transferred to 60 x 15 mm plastic Petri dishes and photolysis was carried out for 3 min by exposure to a longwave (366-nm) UV lamp (Blak-Ray; Ultraviolet Products) placed 10 cm from the cell samples. The cells were then transferred to polypropylene tubes, washed three times, and solubilized with 1% Triton X-100 containing various combinations of protease inhibitors (bacitracin, BzlSO2F, MalNEt). The protocols for the experiments designed to study internalization and processing of the labeled insulin-receptor complexes (i.e., incubation at 16'C or 370C before trypsinization and solubilization) are described in the figure legends..
Polyacrylamide Gel Electrophoresis and Autoradiography. The solubilized proteins from the photoaffinity labeled cells were analyzed by NaDodSO4/polyacrylamide gel electrophoresis according to the method of Laemmli (18) . The samples were boiled for 2 min in Laemmli's sample buffer in the presence or absence of dithiothreitol before application to the gels. The gels were stained with Coomassie brilliant blue, destained, dried, and autoradiographed at -70°C using Kodak X-Omat AR film and Cronex Lightning Plus (Dupont) intensifying screen. The Mr markers used were myosin (200,000), 13-galactosidase (116,000), phosphorylase B (94,000), bovine serum albumin (68,000), and ovalbumin (43,000).
RESULTS
Characteristics of NAPA-DP-'25I-Insulin Binding to Adipocytes. The time course of NAPA-DP-125I-insulin binding to isolated adipocytes at a saturating concentration (80 ng/ml) of photoreactive insulin derivative is shown in Fig. 1 . Binding was rapid, becoming half-maximal in 1 to 2 min and maximal in 10-15 min ofincubation at 16°C. Once binding equilibrium was reached, it remained constant for up to 90 min of incubation. Despite the high concentration of radiolabeled ligand used (to maximize the amount of labeled insulin-receptor complex), nonspecific binding remained at =23% of the total bound.
The effect of photolysis on the dissociation of bound NAPA-DP-125I-insulin from adipocytes is shown in Fig. 2 . After max- imal binding at 160C, incubation of the cells in fresh buffer at 37°C in the dark resulted in rapid loss ofcell-associated NAPA-DP-125I-insulin (100% loss within 90 min). In contrast, UV irradiation of the bound NAPA-DP-125I-insulin followed by incubation at 37°C resulted in decreased dissociation from the cells. At were incubated in the dark (16"C; 20 min) with NAPA-DP-125I-insulin at 80 ng/ml in the absence (-) or presence (+) of unlabeled insulin at 20 jig/ml. The cells were then washed and photolyzed, further washed, collected by centrifugation, and solubilized with 1% Triton X-100 containing bacitracin (2 mg/ml)/2 mM BzlSO2F (lanes a and b) or 1% Triton X-100 containing 2 mM BzlSO2F/1 mM MaINEt (lanes c). Aliquots of the solubilized samples were then either reduced with 50 mM dithiothreitol and subjected to electrophoresis on a 7.5% acrylamide gel (lanes a) or were subjected to electrophoresis under nonreducing conditions using 5% porous (acrylamide/bisacrylamide, 100:1) gels (lanes b and c). The broken arrow indicates the nonspecifically labeled band. Internalization and Processing of the Photoaffinity-Labeled Insulin Receptors. To study the fate ofthe photoaffinity-labeled insulin receptors, adipocytes photolabeled at 16TC were washed and incubated in fresh buffer at 37TC. Susceptibility to tryptic degradation was used to distinguish between labeled receptors on the cell surface (which should be sensitive to extracellular trypsin) and those in the cell interior (which should be insensitive to extracellular trypsin). As shown in Fig. 4 Upper (set a), when the cells labeled at 16TC were trypsinized without incubation at 37TC, the labeled receptor subunits were completely converted into smaller (predominantly Mr 50,000 and 70,000) tryptic fragments, indicating that, at 160C, a temperature at which endocytosis and internalization is minimal (3, 19) , all of the labeled receptors were on the cell surface and therefore accessible to trypsin in the buffer. In contrast, when the labeled cells were incubated at 37TC for 1 hr, the results shown in Fig. 4 Upper (set b) were obtained. First, a new labeled component (Mr 115,000) was generated by incubation at 370C. Second, some ofthe receptors remaining cell associated at the end of the 1-hr incubation at 37TC were insensitive to trypsin, indicating that this fraction was translocated intracellularly and therefore was inaccessible to extracellular trypsin. Finally, as assessed by densitometric scanning of the autoradiograms (data not shown), of the total initial cell-associated labeled receptors (Fig. 4 Upper, set a) only -50% remained cell associated after 1 hr at 37TC (Fig. 4 Upper, set b). Of the latter, the trypsin-insensitive (intracellular) pool was -30%.
The results obtained when samples from an experiment identical to that described in Fig. 4 Upper were subjected to electrophoresis in the absence of dithiothreitol are shown in Fig.  4 Lower. At 16TC, all of the unreduced Mr 330,000, 295,000, and 260,000 receptor species were degraded by trypsin treatment into major fragments of Mr 140,000 and 84,000-90,000 (Fig. 4 Lower, set a), indicating that at this temperature the receptors were all on the cell surface. However, after 1 hr of incubation at 37TC, only the Mr 260,000 species was found to be insensitive to trypsin (Fig. 4 Lower, set b), indicating that FIG. 4 . Effect of 37C incubation of the photolabeled cells on receptor processing and susceptibility of the labeled receptors to extracellular trypsin. (Upper) Photolabeling of adipocyte insulin receptors was carried out at 16C as described in Fig. 3 . Then, half the labeled cells (set a) were treated with trypsin as indicated and solubilized. The rest of the labeled cells (set b) were incubated at 37C for 1 hr, treated with trypsin as indicated, and solubilized. In each instance, trypsin (200 tg/ml) treatment was for 10 min at 37TC and the process was terminated by adding soybean trypsin inhibitor (400 tsg/ml). The cells were washed and solubilized, and aliquots were reduced with 25 Fig. 4 was occurring intracellularly, we next examined the effects of chloroquine, a lysosomotropic agent (20) . Cloroquine (0.2 mM) had no effect on binding or photolabeling of the receptors at 160C; the same patterns and intensities of the different receptor bands were seen in the absence or presence of chloroquine when electrophoresis was carried out under both reducing (Fig. 5 Upper, lanes 1 and 3) and nonreducing (Fig. 5 Lower, lanes 1 and 3) conditions. At 160C, all of the labeled receptors were on the cell surface in both chloroquine-treated and untreated cells; in each instance, trypsin treatment converted all of the labeled receptors into lower molecular weight tryptic fragments (Fig. 5, lanes 2 and 4) . Fig. 5 (sets b) . Comparison of lanes 6 and 8 in Fig. 5 Upper shows that chloroquine blocked generation of the Mr 115,000 component and increased the amount of the trypsin-insensitive (intracellular) Mr 125,000 component, as shown by the increased intensity of this band in the presence of chloroquine. Electrophoresis under nonreducing conditions (Fig. 5 Lower, lane 6) showed that, in the absence of chloroquine, only the Mr 260,000 species was intracellular (trypsin insensitive) whereas, in the presence of chloroquine (Fig. 5 Lower, lane 8), all the three unreduced receptor species (Mr 330,000, 295,000, and 260,000) were intracellular (trypsin insensitive), thus indicating that chloroquine blocked further intracellular processing and degradation of the Mr 330,000 and 295,000 species.
DISCUSSION
The process of insulin-induced receptor loss, termed down regulation, first reported in IM-9 lymphocytes by Gavin et aL (21) , has been extensively documented in vitro in various other cell systems (4) (5) (6) (7) . Several in vivo studies have also shown a significant inverse relationship between ambient insulin levels and cellular receptor concentrations (22) , with amelioration of the hyperinsulinemia resulting in return of the receptor concentration to normal (23) . Thus, although receptor down regulation may serve an important regulatory function for overall insulin action, the mechanism(s) by which the process takes place and the metabolic fate ofthe insulin receptor are poorly understood. Until recently, a major obstacle in this area has been the lack of appropriate techniques with which the receptor can be followed directly. In the present study, we have used photoaffinity labeling to follow the fate of the insulin-receptor complex from its formation on the adipocyte surface to its intracellular translocation and subsequent molecular processing.
The major findings of this study are that (i) insulin-receptor complexes are internalized in intact adipocytes at physiologic temperatures, (ii) cellular processing of the internalized receptors occurs, as evidenced by generation ofthe Mr115,000 component from the Mr 125,000 receptor subunit and disappearance of the Mr 330,000 and 295,000 receptor species, and (iii) receptor processing takes place at a chloroquine-sensitive intracellular site(s).
We have used the photoreactive derivative NAPA-DP-insulin for our studies because it has been well characterized and retains most of the biological activity of insulin (14) (15) (16) (24, 25) and biosynthetic labeling (26, 27 The appearance of the three unreduced receptor species (Mr 330,000, 295,000, and 260,000) in cells labeled and solubilized at 160C (Fig. 3, lanes c; Fig. 4 Lower, set a; and Fig. 5 Lower, set a) raised the question as to whether the insulin receptor normally exists in these heterogeneous forms or whether these species were generated due to the action(s) of intracellular proteolytic enzyme(s) that normally processes the receptor intracellularly in intact cells but were now released after solubilization of the labeled cells with the nondenaturing detergent Triton X-100. In each ofthe above instances, the receptors were all on the cell surface at 16 (28) , who also showed that in vitro incubation of adipocyte plasma membrane insulin receptors with a lysosome-rich subeellular fraction from adipocytes results in a sim-ilar conversion ofthe insulin receptor into three heterogeneous forms.
Our interpretation of our results is that the trypsin-insensitive receptors represent the internalized pool ofreceptors while the trypsin-sensitive receptors represent those on the cell surface. This approach has been used previously to successfully identify internalized epidermal growth factor receptors in 3T3 cells (29) . The results in Fig. 4 show that incubation of photolabeled adipocytes at 370C results in internalization ofa portion of the labeled receptors as well as in the molecular processing of the internalized receptors. Processing of the receptor is evidenced by the generation of the Mr 115,000 component (Fig.   4 Upper, set b) and by the disappearance of the M, 330,000 and 295,000 species from the intracellular receptor compartment (Fig. 4 Lower, set b) after incubation at 370C.
To further substantiate that insulin receptor processing takes place intracellularly, we investigated the effects ofchloroquine, an agent that has lysosomotropic effects (20) , on receptor processing. The results (Fig. 5) show that chloroquine (i) increased the trypsin-insensitive (intracellular) receptor pool, (ii) blocked generation of the Mr 115,000 component from the Mr 125,000 subunit, and (iii) prevented intracellular disappearance of the Mr 330,000 and 295,000 receptor species. It is possible that chloroquine may affect intracellular processes other than lysosomal function, but these results are consistent with the possibility that lysosomes are involved in the processing of internalized insulin receptors. This formulation is supported by previous findings of Massague et al. (28) that in vitro incubation ofadipocyte plasma membranes with lysosome-rich subcellular fractions results in a pattern of processing of insulin receptors (unreduced forms) that is similar to the intracellular processing demonstrated here (Fig. 5 Lower, set b). The generation of the Mr 115,000 component from the Mr 125,000 subunit (Figs. 4 Upper and 5 Upper) and the partial trypsin sensitivity of this component (Fig. 4 Upper, set b) suggest that a portion ofit may be generated on the cell surface, probably due to cell lysis and release of intracellular degradative enzymes. However, since chloroquine inhibits its formation (Fig. 5 Upper, set b), it appears that the Mr 115,000 component is generated predominantly intracellularly and that it represents a proteolytic degradation product or a deglycosylated form of the Mr 125,000 subunit.
In summary, we have shown that insulin-receptor complexes are internalized in isolated adipocytes and then processed intracellularly at achloroquine-sensitive intracellular site(s). Thus, it will be of interest to further use the photoaffinity labeling technique for studies of possible insulin receptor recycling and to investigate the subcellular location(s) and the detailed mechanisms of receptor processing. 
